tazorac

Generic: tazarotene

Labeler: almirall, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name tazorac
Generic Name tazarotene
Labeler almirall, llc
Dosage Form CREAM
Routes
CUTANEOUS
Active Ingredients

tazarotene .1 mg/g

Manufacturer
Almirall, LLC

Identifiers & Regulatory

Product NDC 16110-916
Product ID 16110-916_ee97b76e-eb11-4165-ae85-1277eba9ff35
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021184
Listing Expiration 2026-12-31
Marketing Start 2020-02-03

Pharmacologic Class

Established (EPC)
retinoid [epc]
Chemical Structure
retinoids [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16110916
Hyphenated Format 16110-916

Supplemental Identifiers

UPC
0316110915609 0316110916606 0316110915302 0316110916309
UNII
81BDR9Y8PS
NUI
N0000175607 M0018962

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tazorac (source: ndc)
Generic Name tazarotene (source: ndc)
Application Number NDA021184 (source: ndc)
Routes
CUTANEOUS
source: ndc

Resolved Composition

Strengths
  • .1 mg/g
source: ndc
Packaging
  • 1 TUBE in 1 CARTON (16110-916-30) / 30 g in 1 TUBE
  • 1 TUBE in 1 CARTON (16110-916-60) / 60 g in 1 TUBE
source: ndc

Packages (2)

16110-916-30 1 TUBE in 1 CARTON (16110-916-30) / 30 g in 1 TUBE 16110-916-60 1 TUBE in 1 CARTON (16110-916-60) / 60 g in 1 TUBE

Ingredients (1)

tazarotene (.1 mg/g)

Linked Drug Pages (1)

TAZORAC ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["CUTANEOUS"], "spl_id": "ee97b76e-eb11-4165-ae85-1277eba9ff35", "openfda": {"nui": ["N0000175607", "M0018962"], "upc": ["0316110915609", "0316110916606", "0316110915302", "0316110916309"], "unii": ["81BDR9Y8PS"], "spl_set_id": ["021744d1-a6d7-4ad6-99c2-7187c24e64c6"], "pharm_class_cs": ["Retinoids [CS]"], "pharm_class_epc": ["Retinoid [EPC]"], "manufacturer_name": ["Almirall, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (16110-916-30)  / 30 g in 1 TUBE", "package_ndc": "16110-916-30", "marketing_start_date": "20200203"}, {"sample": false, "description": "1 TUBE in 1 CARTON (16110-916-60)  / 60 g in 1 TUBE", "package_ndc": "16110-916-60", "marketing_start_date": "20200203"}], "brand_name": "TAZORAC", "product_id": "16110-916_ee97b76e-eb11-4165-ae85-1277eba9ff35", "dosage_form": "CREAM", "pharm_class": ["Retinoid [EPC]", "Retinoids [CS]"], "product_ndc": "16110-916", "generic_name": "tazarotene", "labeler_name": "Almirall, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TAZORAC", "active_ingredients": [{"name": "TAZAROTENE", "strength": ".1 mg/g"}], "application_number": "NDA021184", "marketing_category": "NDA", "marketing_start_date": "20200203", "listing_expiration_date": "20261231"}